|
|
Volumn 16, Issue 11, 2017, Pages 739-741
|
|
Landmark gene therapy poised for US approval
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADENO ASSOCIATED VIRUS VECTOR;
ARTICLE;
DRUG APPROVAL;
DRUG COST;
DRUG SAFETY;
FOOD AND DRUG ADMINISTRATION;
GENE DELIVERY SYSTEM;
GENE THERAPY;
HUMAN;
PRIORITY JOURNAL;
REGENERATIVE MEDICINE;
UNITED STATES;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ECONOMICS;
LEGISLATION AND JURISPRUDENCE;
PROCEDURES;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
GENETIC THERAPY;
HUMANS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 85032632999
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd.2017.212 Document Type: Article |
|
Times cited : (12)
|
|
References (0)
|